Hot Chips - Stock recommendations for your portfolio
Suparna / 08 Mar 2012
DSIJ's stock recommendations
INDRAPRASTHA GAS | BSE Code: 532514 | Volume: 245000 | CMP: Rs 359
After having hiked the price of CNG by Rs 1.75/kg at the end of December 2011, Indraprastha Gas (IGL) has announced another hike of Rs 1.70/kg, taking the CNG prices in Delhi to Rs 35.45/kg. The price hike will provide a significant boost to IGL’s profitability going forward. This hike and the consequent improved profitability will help the company in meeting its FY12 projections. The hike in prices will act as a boon for the company and is likely to take the EBITDA margins northward. Given the robust volume growth, which is being incrementally driven at the margin by short-term/spot LNG, this price hike significantly raises the likelihood of the EBITDA margins reverting to around Rs 5 per standard cubic metre levels in the near term. The company looks like an attractive candidate for one’s portfolio from a medium-term perspective.
| Last Seven Days' Volume Table (No. of Shares) | |
|---|---|
| Days | Volume |
| 28-Feb-12 | 29685 |
| 29-Feb-12 | 166964 |
| 1-Mar-12 | 196227 |
| 2-Mar-12 | 79682 |
| 3-Mar-12 | 3418 |
| 5-Mar-12 | 365152 |
| 6-Mar-12 | 245000 |
[PAGE BREAK]
TORRENT PHARMACEUTICALS | BSE Code: 500420 | Volume: 142 | CMP: Rs 565
Torrent Pharma has 36 brands leading in their respective molecule segments, of which six feature in the list of India’s top 300 pharma brands. With new product launches, the company has been able to maintain its dominant position in the domestic Cardiovascular and Central Nervous System segments. In line with the industry trend, Torrent Pharma has maintained its tilt towards the chronic profile over the acute one. It has successfully increased its footprint in international markets, which contributed around 51 per cent to its total revenues in FY11. Brazil contributes majorly to its international division, with 27 successful drug launches there. The management has also taken corrective action in terms of addition and improvement in efficiency of its field force. Apart from the regular 25-30 drug launches in the domestic market every year, the company is planning to enter new therapeutic segments like oncology and infertility to widen its offerings. One can look at the scrip from a medium-term perspective.
| Last Seven Days' Volume Table (No. of Shares) | |
|---|---|
| Days | Volume |
| 28-Feb-12 | 304 |
| 29-Feb-12 | 677 |
| 1-Mar-12 | 9426 |
| 2-Mar-12 | 3744 |
| 3-Mar-12 | -- |
| 5-Mar-12 | 434 |
| 6-Mar-12 | 142 |
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.